Complication of enoxaparin(Alborz Daroo) compared with clexane(Aventis, Lupin) in patient whit Acute coronary syndrome
Phase 3
- Conditions
- Acute coronary syndrome.Acute ischaemic heart disease, unspecified
- Registration Number
- IRCT2015090821979N2
- Lead Sponsor
- Shahroud University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
all patients with ACS (STEMI, NON STEMI, unstable angina) shahroud referring to Imam Hossein hospital.
Exclusion criteria: the sensitivity of the lamina propria Anagza; those who have active bleeding; thrombocytopenia; previously received heparin.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major bleeding. Timepoint: Until discharge from hospital. Method of measurement: Observation.;Minor bleeding. Timepoint: Until discharge from hospital. Method of measurement: Sheet urinary analysis.;Thrombocytopenia. Timepoint: Until discharge from hospital. Method of measurement: Patient test page.;PTT. Timepoint: Until discharge from hospital. Method of measurement: Patient test page.
- Secondary Outcome Measures
Name Time Method